| Gene symbol | KLK2 | Synonyms | KLK2A2, hGK-1, hK2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.33 | dbXrefs | |
| Description | kallikrein related peptidase 2 | ||||
| GTO ID | GTC2774 |
| Trial ID | NCT05022849 |
| Disease | Prostatic Adenoma |
| Altered gene | KLK2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | JNJ-75229414 |
| Co-treatment | Anti-AR agents |
| Phase | Phase1 |
| Recruitment status | Active, Not Recruiting |
| Title | A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer Participants |
| Year | 2021 |
| Country | United States |
| Company sponsor | Janssen Research & Development, LLC |
| Other ID(s) | CR108972|75229414MPC1001 |
| Cohort 1 | |||||||||
|
|||||||||